Publications
研究業績
すべての研究業績
医薬品・医療機器のレギュラトリーサイエンス
食品・化学物質のレギュラトリーサイエンス
デジタルヘルス・医療の社会実装
労働・生活と生体情報
創薬・診断技術と研究開発
イノベーション・経営と情報分析
創薬・診断技術と研究開発
Strategic manufacturing and versatile applications to expand the mRNA therapeutic frontier
Masashi Abe; Yuri Sano-Fujimoto; Yu Nishida; Kota Kodama; Shuto Miyashita; Shintaro Sengoku
Drug Discovery Today. 2026; 31(5): 104774.
https://doi.org/10.1016/j.drudis.2026.104774
創薬・診断技術と研究開発
Evolution of the division of labor for First-in-Class Drugs: A Quantitative Analysis of Trends across Company Types, Modalities, and Therapeutic Areas (2012–2024)
Yusuke Izumiya; Yoshiyuki Kobayashi; Itsuki Kageyama; Shintaro Sengoku; Kota Kodama
Drug Discovery Today. 2026; 31(3): 104669.
https://doi.org/10.1016/j.drudis.2026.104669
創薬・診断技術と研究開発
Advancing ex vivo gene therapy: the role of lentiviral vectors and organizational collaboration
Yuri Sano-Fujimoto; Yu Nishida; Kota Kodama; Shuto Miyashita; Shintaro Sengoku
Drug Discovery Today. 2025; 30(12): 104510.
https://doi.org/10.1016/j.drudis.2025.104510
創薬・診断技術と研究開発
Mass spectrometry-based methods for biofluid biomarkers for progressive diseases: amyloid peptides and dystrophins
Makoto Niwa; Kenta Noda; Yoshiyuki Kobayashi; Itsuki Kageyama; Kota Kodama
Bioanalysis. 2025; 17(10): 671–680.
https://doi.org/10.1080/17576180.2025.2515011
創薬・診断技術と研究開発
Multi-layer platform coordination for open innovation in oligonucleotide therapeutics
Yayoi Kawata; Taisuke Ichimaru; Masakazu Kogami; Kota Kodama; Shuto Miyashita; Shintaro Sengoku
Drug Discovery Today. 2025; 30(2): 104288.
https://doi.org/10.1016/j.drudis.2025.104288